전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
do not
- tużax is- soluzzjoni fil- kunjetti jekk din tkun ta ’ kulur imdennes jew jekk ikun fiha materjal
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
do not:
tagĦmilx:
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
do not have
ma ghandiex
마지막 업데이트: 2019-10-22
사용 빈도: 1
품질:
추천인:
do not inject.
tinjettahiex.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
추천인:
insulin does not cross the placental barrier.
l-insulina ma taqsamx għal ġol-plaċenta.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
추천인:
dopamine does not cross the blood-brain barrier.
dopamine ma jaqsamx il-barriera ta’ bejn id-demm u l-moħħ.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
추천인:
certolizumab pegol does not cross-react with rodent tnf.
certolizumab pegol ma jagħmilx reazzjoni ma tnf fl-annimali ġerriema.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
추천인:
tasonermin did not cross the placenta or pass into necrotic tumour.
tasonermin ma jaqsamx il- plaċenta u lanqas tgħaddi għal ġo tumur nekrotiku.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
추천인:
does not cross at level with any railway or tramway track, or footpath.
ma taqsamx f’livell mal-ebda binarju ferrovjarju jew tat-tramm, jew mogħdija tar-riġel.
마지막 업데이트: 2017-04-06
사용 빈도: 1
품질:
추천인:
infliximab does not cross react with tnfα from species other than human and chimpanzees.
infliximab ma jagħmilx cross reaction ma’ tnfα minn speċi oħra barra mill-bniedem u x-ximpanżì.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
추천인:
carbidopa does not cross the blood-brain barrier at clinically relevant doses.
carbidopa ma jaqsamx il-barriera bejn id-demm u l-moħħ f’dożi klinikament rilevanti.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
추천인:
patients in the placebo arm did not cross-over to everolimus at the time of progression.
il-pazjenti fil-grupp tal-plaċebo ma qelbux għal everolimus waqt il-progressjoni.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
추천인:
fondaparinux does not cross-react with sera from patients with heparin-induced thrombocytopaenia.
fondaparinux ma jagħmilx cross reaction ma’ sera minn pazjenti bi tromboċitopenja indotta bl- eparina.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
추천인:
patients in the placebo + exemestane arm did not cross over to everolimus at the time of progression.
pazjenti fil-grupp mogħti plaċebo + exemestane ma għaddewx għal everolimus fil-perijodu ta’ progressjoni.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
추천인:
insulin does not cross the placental barrier. caution should be exercised when prescribing to pregnant women.
wieħed għandu joqgħod attent meta jikteb riċetta għal din il- mediċina għal nisa tqal.
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
추천인:
a third isolate which carried a substitution at position 236 of rt was not cross-resistant to efavirenz.
it-tielet iżolat li kellu sostituzzjoni fil-pożizzjoni 236 ta’ rt ma kellux reżistenza msallba għal efavirenz.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
추천인:
patients with heparin induced thrombocytopenia fondaparinux does not bind to platelet factor 4 and does not cross-react with sera from patients with du
l- effikaċja u s- sigurta` ta ’ fondaparinux ma ot
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
추천인:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
pegvisomant is highly selective for the gh receptor, and does not cross-react with other cytokine receptors, including prolactin.
pegvisomant huwa selettiv ħafna għar-riċettur gh u ma jagħmilx reazzjoni ma’ riċetturi cytokine oħra, inkluż prolaktin.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
추천인:
of the 271 adult itp patients receiving romiplostim in the itp clinical programme one patient developed antibodies capable of neutralising the activity of romiplostim but these antibodies did not cross react with endogenous tpo.
mill- 271 pazjenti adulti b’ itp li rċevew romiplostim fil- programm kliniku ta ’ itp, pazjent wieħed żviluppa antikorpi li kapaċi jinnewtralizzaw l- attività ta ’ romiplostim iżda dawn l- antikorpi ma kellhomx reazzjoni ma ’ tpo endoġenu.
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
추천인:
fondaparinux does not bind to platelet factor 4 and does not cross-react with sera from patients with heparin induced thrombocytopenia (hit) type ii.
fondaparinux ma jintrabatx mal-fattur 4 tal-plejtlets u ma jirreaġixxix mas-serum minn pazjenti b’ tromboċitopenja indotta bl- eparina (tie) tat-tip ii.
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
추천인: